Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| DBV Technologies S.A.ADS(DBVT) | 996,825 | 5,213,361 | +4,216,536 | $19.11M | $108.91M | 8.41% | +$89.80M |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | $79.16M | $108.68M | 8.39% | +$29.52M |
| Aktis Oncology, Inc.(AKTS) | 0 | 4,835,872 | +4,835,872 | $0 | $86.51M | 6.68% | +$86.51M |
| Liquidia Corporation(LQDA) | 1,400,869 | 1,405,158 | +4,289 | $48.32M | $53.03M | 4.10% | +$4.71M |
| Alumis Inc | 2,401,992 | 2,386,529 | -15,463 | $23.44M | $52.58M | 4.06% | +$29.13M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,655,256 | 1,660,696 | +5,440 | $41.08M | $52.31M | 4.04% | +$11.24M |
| Revolution Medicines, Inc.(RVMD) | 505,672 | 506,776 | +1,104 | $40.28M | $49.28M | 3.81% | +$9.01M |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,303,373 | 1,306,261 | +2,888 | $35.48M | $44.19M | 3.41% | +$8.71M |
| Corcept Therapeutics Incorporated(CORT) | 0 | 985,700 | +985,700 | $0 | $39.73M | 3.07% | +$39.73M |
| Trevi Therapeutics, Inc.(TRVI) | 3,287,087 | 3,298,430 | +11,343 | $41.15M | $39.35M | 3.04% | -$1.80M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 423,982 | +423,982 | $0 | $35.58M | 2.75% | +$35.58M |
| Xenon Pharmaceuticals Inc.(XENE) | 485,620 | 588,706 | +103,086 | $21.77M | $34.23M | 2.64% | +$12.47M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 1,811,082 | +1,811,082 | $0 | $33.76M | 2.61% | +$33.76M |
| Travere Therapeutics, Inc.(TVTX) | 0 | 1,133,365 | +1,133,365 | $0 | $33.67M | 2.60% | +$33.67M |
| Evommune, Inc.(EVMN) | 113,022 | 1,455,863 | +1,342,841 | $1.93M | $33.47M | 2.58% | +$31.54M |
| Cytokinetics, Incorporated(CYTK) | 0 | 500,000 | +500,000 | $0 | $32.95M | 2.54% | +$32.95M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,337,702 | 1,340,733 | +3,031 | $28.11M | $31.32M | 2.42% | +$3.21M |
| Context Therapeutics Inc.(CNTX) | 10,679,391 | 10,679,391 | 0 | $15.70M | $27.98M | 2.16% | +$12.28M |
| Forte Biosciences, Inc. | 0 | 1,000,682 | +1,000,682 | $0 | $25.92M | 2.00% | +$25.92M |
| Palvella Therapeutics, Inc.(PVLA) | 205,745 | 206,404 | +659 | $21.54M | $25.73M | 1.99% | +$4.19M |
| Dyne Therapeutics, Inc.(DYN) | 1,405,388 | 1,408,152 | +2,764 | $27.49M | $25.53M | 1.97% | -$1.96M |
| Stoke Therapeutics, Inc.(STOK) | 770,289 | 767,038 | -3,251 | $24.45M | $24.97M | 1.93% | +$525.8K |
| Corvus Pharmaceuticals, Inc.(CRVS) | 2,743,671 | 1,674,875 | -1,068,796 | $21.13M | $24.50M | 1.89% | +$3.38M |
| Relay Therapeutics, Inc.(RLAY) | 2,232,451 | 2,359,586 | +127,135 | $18.89M | $23.48M | 1.81% | +$4.59M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 328,869 | 329,750 | +881 | $26.93M | $23.13M | 1.79% | -$3.80M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,798,717 | 1,803,945 | +5,228 | $14.71M | $22.86M | 1.77% | +$8.14M |
| uniQure N.V.(QURE) | 1,381,628 | 1,369,231 | -12,397 | $33.06M | $22.39M | 1.73% | -$10.68M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,173,376 | 1,176,928 | +3,552 | $18.40M | $19.36M | 1.50% | +$961.9K |
| Natera, Inc.(NTRA) | 93,551 | 93,074 | -477 | $21.43M | $18.61M | 1.44% | -$2.82M |
| Climb Bio, Inc.(CLYM) | 2,671,480 | 2,593,439 | -78,041 | $10.69M | $17.77M | 1.37% | +$7.08M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 531,200 | 733,966 | +202,766 | $15.43M | $17.29M | 1.34% | +$1.87M |
| UroGen Pharma Ltd.(URGN) | 941,378 | 943,803 | +2,425 | $22.05M | $16.97M | 1.31% | -$5.08M |
| Bright Minds Biosciences Inc.(DRUG) | 230,147 | 212,175 | -17,972 | $17.96M | $15.48M | 1.20% | -$2.48M |
| Zymeworks Inc.(ZYME) | 0 | 565,249 | +565,249 | $0 | $14.15M | 1.09% | +$14.15M |
| Belite Bio, IncADS(BLTE) | 87,760 | 88,045 | +285 | $14.04M | $14.04M | 1.08% | -$195 |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 649,873 | +649,873 | $0 | $12.71M | 0.98% | +$12.71M |
| enGene Holdings, Inc. COM | 1,840,898 | 1,845,373 | +4,475 | $16.62M | $12.57M | 0.97% | -$4.06M |
| ABIVAX Société AnonymeADS(ABVX) | 56,316 | 107,268 | +50,952 | $7.59M | $11.94M | 0.92% | +$4.35M |
| Allogene Therapeutics, Inc. | 0 | 2,242,933 | +2,242,933 | $0 | $5.47M | 0.42% | +$5.47M |
| Aclaris Therapeutics, Inc.(ACRS) | 0 | 391,918 | +391,918 | $0 | $1.47M | 0.11% | +$1.47M |
| Werewolf Therapeutics, Inc.(HOWL) | 1,393,557 | 1,208,810 | -184,747 | $883.5K | $1.01M | 0.08% | +$122.9K |
| Maze Therapeutics, Inc.(MAZE) | 81,145 | 0 | -81,145 | $3.36M | $0 | — | -$3.36M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 96,780 | 0 | -96,780 | $56.36M | $0 | — | -$56.36M |
| Protagonist Therapeutics Inc | 199,471 | 0 | -199,471 | $17.42M | $0 | — | -$17.42M |
| PTC Therapeutics, Inc.(PTCT) | 430,013 | 0 | -430,013 | $32.66M | $0 | — | -$32.66M |
| RAPT Therapeutics Inc | 397,906 | 0 | -397,906 | $13.48M | $0 | — | -$13.48M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,586,076 | 0 | -1,586,076 | $5.57M | $0 | — | -$5.57M |
| Sarepta Therapeutics, Inc.(SRPT) | 70,000 | 0 | -70,000 | $1.51M | $0 | — | -$1.51M |
| Ventyx Biosciences Inc | 1,639,061 | 0 | -1,639,061 | $14.80M | $0 | — | -$14.80M |